News

FlexTouch features easy-touch which enables patients to use little force for injecting the insulin at any dose. The company expects to roll out the insulin pen in EU

The patent allows Arch Biopartners to develop methods to prevent or inhibit the growth of biofilm formation on biotic and abiotic surfaces. The method modifies solid surfaces to

The results of the trial demonstrated that patients with HER2-positive metastatic breast cancer (mBC) who have been administered combined medicine of pertuzumab and Herceptin (trastuzumab), in addition to

He will also serve as a member of executive management board for Merck Serono. Previosly, he worked as a chief commercial officer for EMD Serono and was responsible

Under the contracts, Astellas will develop and commercialize TransVax, however Vical will take care of the co-promotion in US. Additionally, Vical will support Astellas in manufacturing, development and

The open-label, two-arm dose escalation trial intends to establish the maximum tolerated dose of BMN 673. The trial will also evaluate the pharmacodynamics, pharmacokinetics, safety and preliminary efficacy

J&J signed a definitive agreement to acquire JB Chemicals in 26 May 2011, as part of its plan to widen its presence in Russia. The acquisition includes multi-symptom

Firecrest, with its web-based solution, provides study information, training manuals for the study sites. ICON CEO Peter Gray said delivering consistent, real-time information to sites and a clear

The approval for Benlysta was granted as an additional therapy for the adult patients suffering from active autoantibody-positive systemic lupus erythematosus (SLE) with high degree of disease activity.